MET gene amplification is a mechanism of resistance to entrectinib in ROS1+ NSCLC
MET 基因扩增是 ROS1+ NSCLC 对恩曲替尼产生耐药性的机制
期刊:Thoracic Cancer
影响因子:2.3
doi:10.1111/1759-7714.14656
Logan C Tyler, Anh T Le, Nan Chen, Hala Nijmeh, Liming Bao, Timothy R Wilson, David Chen, Brian Simmons, Kristen M Turner, Dean Perusse, Shailaja Kasibhatla, Jason Christiansen, Arkadiusz Z Dudek, Robert C Doebele
